HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

Related Keywords

United States ,United Kingdom ,Kumar Budur ,Luis Sanay ,Paragon Biosciences ,European Medicines Agency ,Drug Administration ,Exchange Commission ,Prnewswire Harmony Biosciences Holdings Inc ,Company Nasdaq ,American College Of Neuropsychopharmacology Annual Meeting ,European Union ,Biosciences Holdings ,American College ,Neuropsychopharmacology Annual Meeting ,Chief Medical Officer ,Irritable Behaviors ,Qualitative Interview Study ,Conceptual Framework ,United States Food ,Harmony Biosciences ,Plymouth Meeting ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Report ,Current Report ,Biosciences Media Contact ,Biosciences Investor Contact ,